Miksa Michael, Kaushik Shubhi, Antovert Gerald, Brown Sakar, Ushay H Michael, Katyal Chhavi
All authors: Children's Hospital at Montefiore and Albert Einstein College of Medicine, Pediatric Critical Care Medicine, New York, NY.
Crit Care Explor. 2021 Feb 12;3(2):e0334. doi: 10.1097/CCE.0000000000000334. eCollection 2021 Feb.
Acute asthma management has improved significantly across hospitals in the United States due to implementation of standardized care pathways. Management of severe acute asthma in ICUs is less well studied, and variations in management may delay escalation and/or deescalation of therapies and increase length of stay. In order to standardize the management of severe acute asthma in our PICU, a nurse- and respiratory therapist-driven critical care asthma pathway was designed, implemented, and tested.
Cross-sectional study of severe acute asthma at baseline followed by implementation of a critical care asthma pathway.
Twenty-six-bed urban quaternary PICU within a children's hospital.
Patients 24 months to 18 years old admitted to the PICU in status asthmaticus. Patients with severe bacterial infections, chronic lung disease, heart disease, or immune disorders were excluded.
Implementation of a nurse- and respiratory therapist-driven respiratory scoring tool and critical care asthma pathway with explicit escalation/deescalation instructions.
Primary outcome was PICU length of stay. Secondary outcomes were time to resolution of symptoms and hospital length of stay. Compliance approached 90% for respiratory score documentation and critical care asthma pathway adherence. Severity of illness at admission and clinical baseline characteristics were comparable in both groups. Pre intervention, the median ICU length of stay was 2 days (interquartile range, 1-3 d) with an overall hospital length of stay of 4 days (interquartile range, 3-6 d) ( = 74). After implementation of the critical care asthma pathway, the ICU length of stay was 1 day (interquartile range, 1-2 d) ( = 0.0013; = 78) with an overall length of stay of 3 days (interquartile range, 2-3.75 d) ( < 0.001). The time to resolution of symptoms was reduced from a median of 66.5 hours in the preintervention group to 21 hours in the postintervention compliant group ( = 0.036).
The use of a structured critical care asthma pathway, driven by an ICU nurse and respiratory therapist, is associated with faster resolution of symptoms, decreased ICU, and overall hospital lengths of stay in children admitted to an ICU for severe acute asthma.
由于实施了标准化护理路径,美国各医院的急性哮喘管理有了显著改善。重症监护病房(ICU)中重症急性哮喘的管理研究较少,管理差异可能会延迟治疗的升级和/或降级,并延长住院时间。为了规范我们儿科重症监护病房(PICU)中重症急性哮喘的管理,设计、实施并测试了一种由护士和呼吸治疗师主导的重症监护哮喘路径。
对重症急性哮喘进行基线横断面研究,随后实施重症监护哮喘路径。
一家儿童医院内拥有26张床位的城市四级PICU。
因哮喘持续状态入住PICU的24个月至18岁患者。排除患有严重细菌感染、慢性肺病、心脏病或免疫疾病的患者。
实施由护士和呼吸治疗师主导的呼吸评分工具和重症监护哮喘路径,并给出明确的升级/降级指示。
主要结局是PICU住院时间。次要结局是症状缓解时间和住院时间。呼吸评分记录和重症监护哮喘路径依从性的依从率接近90%。两组入院时的疾病严重程度和临床基线特征具有可比性。干预前,PICU住院时间中位数为2天(四分位间距,1 - 3天),总住院时间为4天(四分位间距,3 - 6天)(n = 74)。实施重症监护哮喘路径后,PICU住院时间为1天(四分位间距,1 - 2天)(P = 0.0013;n = 78),总住院时间为3天(四分位间距,2 - 3.75天)(P < 0.001)。症状缓解时间从干预前组的中位数66.5小时缩短至干预后依从组的21小时(P = 0.036)。
由ICU护士和呼吸治疗师主导的结构化重症监护哮喘路径的使用,与入住ICU治疗重症急性哮喘的儿童症状更快缓解、ICU住院时间和总住院时间缩短相关。